The prevalence of multidose vial contamination by aerobic bacteria in a major teaching hospital, Shiraz, Iran, 2006

American Journal of Infection Control

Volumn 37, Issue 9, 2009, Pages 773-777

  Motamedifar, Mohammad ^a   Askarian, Mehrdad ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ACTINOMYCES VISCOSUS; AEROBIC BACTERIUM; ARTICLE; DRUG STORAGE; GRAM POSITIVE BACTERIUM; INFECTION CONTROL; IRAN; MICROBIAL CONTAMINATION; NURSE; PREVALENCE; SPAIN; STAPHYLOCOCCUS EPIDERMIDIS; TEACHING HOSPITAL; TEMPERATURE;

BACTERIA, AEROBIC; DRUG CONTAMINATION; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HOSPITALS, TEACHING; HUMANS; INFUSIONS, PARENTERAL; IRAN; PREVALENCE;

EID: 71249159164     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajic.2008.12.009     Document Type: Article

References (24)

1. Longfield R.N., Smith L.P., Longfield J.N., Coberly J., and Cruess D. Multiple-dose vials: persistence of bacterial contaminants and infection control implications. Infect Control 6 (1985) 194-199
2. Nakashima A.K., Highsmith A.K., and Martone W.J. Survival of Serratia marcescens in benzalkonium chloride and in multiple-dose medication vials: relationship to epidemic septic arthritis. J Clin Microbiol 25 (1987) 1019-1021
3. Dade J., Wilcox M., and Kay L. Hazards of multiple use of pharmaceutical solutions. Lancet 356 (2000) 1684-1685
4. Kirschke D.L., Jones T.F., Stratton C.W., Barnett J.A., and Schaffner W. Outbreak of joint and soft-tissue infections associated with injections from a multiple-dose medication vial. Clin Infect Dis 36 (2003) 1369-1373
5. Melnyk P.S., Shevchuk Y.M., Conly J.M., and Richardson C.J. Contamination study of multiple-dose vials. Ann Pharmacother 27 (1993) 274-278
6. Mattner F., and Gastmeier P. Bacterial contamination of multiple-dose vials: a prevalence study. Am J Infect Control 32 (2004) 12-16
7. Moro M.L., Maffei C., Manso E., Morace G., Polonelli L., and Biavasco F. Nosocomial outbreak of systemic candidosis associated with parenteral nutrition. Infect Control Hosp Epidemiol 11 (1990) 27-35
8. Henry B., Plante-Jenkins C., and Ostrowska K. An outbreak of Serratia marcescens associated with the anesthetic agent propofol. Am J Infect Control 29 (2001) 312-315
9. Plott R.T., Wagner Jr. R.F., and Tyring S.K. Iatrogenic contamination of multidose vials in simulated use: a reassessment of current patient injection technique. Arch Dermatol 126 (1990) 1441-1444
10. Stolar M.H. Multiple-dose vials. Am J Hosp Pharm 37 (1980) 185
11. Askarian M., Hosseini R.S., Kheirandish P., and Assadian O. Incidence and outcome of nosocomial infections in female burn patients in Shiraz, Iran. Am J Infect Control 32 (2004) 23-26
12. Askarian M., and Gooran N.R. National nosocomial infection surveillance system-based study in Iran: additional hospital stay attributable to nosocomial infections. Am J Infect Control 31 (2003) 465-468
13. Magee L., Godsiff L., Matthews I., Farrington M., and Park G.R. Anaesthetic drugs and bacterial contamination. Eur J Anaesthesiol Suppl 12 (1995) 41-43
14. Taylor M., Bourke J., and Anderson M. Titrated intravenous opioids from the same syringe: an infection risk?. J Accid Emerg Med 14 (1997) 33-35
15. Trautmann M., Zauser B., Wiedeck H., Buttenschön K., and Marre R. Bacterial colonization and endotoxin contamination of intravenous infusion fluids. J Hosp Infect 37 (1997) 225-236
16. Bach A., Motsch J., Schmidt H., Böttiger B.W., Böhrer H., Martin E., et al. In-use contamination of propofol: a clinical study. Eur J Anaesthesiol 14 (1997) 178-183
17. Bennett S.N., McNeil M.M., Bland L.A., Arduino M.J., Villarino M.E., Perrotta D.M., et al. Postoperative infections traced to contamination of an intravenous anesthetic, propofol. N Engl J Med 333 (1995) 147-154
18. Tresoldi A.T., Padoveze M.C., Trabasso P., Veiga J.F., Marba S.T., von Nowakonski A., et al. Enterobacter cloacae sepsis outbreak in a newborn unit caused by contaminated total parenteral nutrition solution. Am J Infect Control 28 (2000) 258-261
19. von Eiff C., Proctor R.A., and Peters G. Coagulase-negative staphylococci: pathogens have major role in nosocomial infections. Postgrad Med 110 (2001) 63-76
20. Tarr B.D., Campbell R.K., and Workman T.M. Stability and sterility ofbiosynthetic human insulin stored in plastic insulin syringes for 28 days. Am J Hosp Pharm 48 (1991) 2631-2634
21. Stetler H.C., Garbe P.L., Dwyer D.M., Facklam R.R., Orenstein W.A., West G.R., et al. Outbreaks of group A streptococcal abscesses following diphtheria-tetanus toxoid-pertussis vaccination. Pediatrics 75 (1985) 299-303
22. Bijma R., Girbes A.R., Kleijer D.J., and Zwaveling J.H. Preventing central venous catheter-related infection in a surgical intensive-care unit. Infect Control Hosp Epidemiol 20 (1999) 618-620
23. Meier P.A., Fredrickson M., Catney M., and Nettleman M.D. Impact of a dedicated intravenous therapy team on nosocomial bloodstream infection rates. Am J Infect Control 26 (1998) 388-392
24. Bawden J.C., Jacobson J.A., Jackson J.C., Anderson R.K., and Burke J.P. Sterility and use patterns of multiple-dose vials. Am J Hosp Pharm 39 (1982) 294-297